Most research into COVID-19 coronavirus is focused on what it is and how to stop it. Virtually all of that research was on live subjects. Now, a team at The Mount Sinai Hospital is looking at the dead to help them better understand COVID-19’s broad impact on the human body.
Worldwide, travel bans have been implemented to try and stem the tide of COVID-19 coronavirus. Here in the US, Democrat lawmakers heaped scorn on President Trump for his travel bans, calling them racist and xenophobic. Now, a Stanford University study says they have saved millions from infection and death.
A newly identified monoclonal antibody may be the key to developing a safe and highly effective treatment for SARS-CoV-2, the virus that causes COVID-19. Monoclonal antibodies were once thought to be the “magic bullet” in treating disease. Now, they might be a powerful weapon against a dangerous pathogen.
Fox News and some other news outlets have been criticized and accused of misleading the public recently. They reported that US hospitals get paid more for Medicare patients listed as COVID-19 patients and three times as much for virus patients on a ventilator. Is it true?
COVID-19 coronavirus has killed hundreds of thousands of people, sickened millions and crippled the word economy since emerging from Wuhan, China in 2019. Now a team at UNC Chapel Hill is undertaking a massive review of all available research data to find a way to beat it.
We’ve heard a lot about how COVID-19 coronavirus is transmitted and how it effects the body. We were introduced to medical terms like cytokine storm, hydroxychloroquine and viral shedding. But how does the virus do its work? How does it beat our defenses and attack respiratory tissue
The most common symptoms of COVID-19 coronavirus are well-established. They include fever, dry cough and difficulty breathing. But they’re not the only symptoms. In many COVID-19 cases, full onset of the illness is preceded by loss of chemosensory functions, smell and taste.
A number of drugs have been held up as promising treatments for COVID-19 coronavirus. A few have already been put into use. The most well-known of these is Hydroxychloroquine. However, another drug, Remdesivir, is also showing strong results in clinical trials. Could this be the answer for treating COVID-19?
Hydroxychloroquine is under clinical testing in multiple labs. But even without clinical proof of effectiveness, its use to treat COVID-19 is increasing. But according to one poll, plasma from recovered patients may be seen as more effective.
Doctors, nurses and medical professionals all over the world are working long hours diagnosing and treating COVID-19 coronavirus patients. Their choices are being made based on rapidly developing scientific evidence. Could that evidence essentially be “bad intel?”